TD-428 is primarily used in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor of certain enzymes that are involved in the growth and proliferation of cancer cells. Researchers utilize TD-428 to investigate its effects on tumor suppression and to explore its potential as a targeted treatment for specific types of cancers. Additionally, it is employed in preclinical studies to understand its pharmacokinetics and pharmacodynamics, aiding in the development of more effective and safer anticancer drugs. Its application extends to combination therapy studies, where it is tested alongside other therapeutic agents to assess synergistic effects and improve treatment outcomes.